CDC Updates

[niman]

• As of September 17, 2019 at 5pm, 530* cases of lung injury associated with the use of e-cigarette  or vaping products have been reported to CDC from the following states and 1 U.S. territory: AR, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MD, MI, MN, NC, ND, NE, NJ, NM, NV, NY, OH, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY, and USVI. These numbers may change frequently.
• CDC has received complete sex and age data on 373 of 530 cases.
  • Nearly three fourths (72%) of cases are male
  • Two thirds (67%) of cases are 18 to 34 years old
  • 16% of cases are under 18 years and 17% are 35 years or older
• Seven deaths have been confirmed in California (2), Illinois, Indiana, Kansas, Minnesota, and Oregon.
• CDC worked with states to create a case definition to classify confirmed and probable cases in a consistent way. State investigators determine if cases are confirmed or probable after examining the medical records of suspected cases and consulting with the clinical care team to exclude other possible causes of illness. Unlike nationally reportable conditions, these cases are requiring clinicians and public health professionals to interview patients to determine product use and individual behaviors.
• CDC will report numbers of confirmed and probable cases once states have finalized their classification of cases.
• States are in the process of classifying cases. We expect that states and clinicians may look back for older cases based on CDC’s case definition.
• All patients have a reported history of e-cigarette product use, and no consistent evidence of an infectious cause has been discovered. Therefore, the suspected cause is a chemical exposure.
• Based on initial data from certain states we know: Most patients have reported a history of using e-cigarette products containing THC. Many patients have reported using THC and nicotine. Some have reported the use of e-cigarette products containing only nicotine.
• No consistent e-cigarette or vaping product, substance, or additive has been identified in all cases, nor has any one product or substance been conclusively linked to lung disease in patients.
• Initial published reports from the investigation point to clinical similarities among cases. Patients reported a history of e-cigarette use and had similar symptoms and clinical findings. These align with the CDC health advisory released August 30, 2019.
• These investigations are ongoing. CDC will provide updates when more information is available.

*The increase in cases from last week represents both new cases and recent reporting of previously-identified cases to CDC.

https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html

Top of Page

Map of Reported Cases